(2021) Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus. Letters in Drug Design & Discovery. pp. 418-421. ISSN 1570-1808
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
Abstract
The recent pandemic caused by a novel coronavirus known as SARS-CoV-2 has caught the international community by surprise. There is still no effective vaccine or treatment option against this virus. In this perspective, we discussed the potential protective and therapeutic effects of chitosan, as an FDA-approved biomolecule, against COVID-19 and influenza viruses.
| Item Type: | Article |
|---|---|
| Keywords: | Chitosan COVID-19 immune response innate Immunity biotherapeutic macromolecule antiviral activity nanoparticles act adjuvant immunity chitin safety responses polymers vaccine food Pharmacology & Pharmacy |
| Page Range: | pp. 418-421 |
| Journal or Publication Title: | Letters in Drug Design & Discovery |
| Journal Index: | ISI |
| Volume: | 18 |
| Number: | 5 |
| Identification Number: | https://doi.org/10.2174/1570180817999201110114446 |
| ISSN: | 1570-1808 |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.bmsu.ac.ir/id/eprint/9681 |
Actions (login required)
 |
View Item |